Insider Trading History of Swiedler Stuart J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Swiedler Stuart J since 2005. The trader's CIK number is 1312510. At the time of the last reporting, Swiedler Stuart J was the SVP, Clinical Affair of Biomarin Pharmaceutical Inc. (stock ticker symbol BMRN). Also see all insider trading activities at Biomarin Pharmaceutical Inc.


Yearly summary of insider trading at Biomarin Pharmaceutical Inc (BMRN) by Swiedler Stuart J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 BMRN 0 $0 40,000 $1,326,612 40,000 $245,200
2007 BMRN 0 $0 50,000 $960,587 50,000 $213,312
2006 BMRN 0 $0 35,000 $493,632 35,000 $140,000
2005 BMRN 0 $0 30,000 $300,000 0 $0


Insider trading of Biomarin Pharmaceutical Inc (BMRN) by Swiedler Stuart J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-07-01 BMRN Option Ex 15,000 6.13 91,950
2008-07-01 BMRN Sale 15,000 28.34 425,175
2008-04-01 BMRN Option Ex 12,500 6.13 76,625
2008-04-01 BMRN Sale 12,500 35.95 449,400
2008-01-02 BMRN Sale 12,500 36.16 452,037
2008-01-02 BMRN Option Ex 12,500 6.13 76,625
2007-10-01 BMRN Option Ex 12,500 5.07 63,312
2007-10-01 BMRN Sale 12,500 25.07 313,400
2007-07-02 BMRN Option Ex 12,500 4.00 50,000
2007-07-02 BMRN Sale 12,500 18.18 227,250
2007-04-02 BMRN Sale 12,500 17.30 216,237
2007-04-02 BMRN Option Ex 12,500 4.00 50,000
2007-01-03 BMRN Option Ex 12,500 4.00 50,000
2007-01-03 BMRN Sale 12,500 16.30 203,700
2006-11-01 BMRN Option Ex 12,500 4.00 50,000
2006-11-01 BMRN Sale 12,500 15.92 198,975
2006-08-01 BMRN Sale 12,500 14.34 179,187
2006-08-01 BMRN Option Ex 12,500 4.00 50,000
2006-02-01 BMRN Option Ex 10,000 4.00 40,000
2006-02-01 BMRN Sale 10,000 11.55 115,470
2005-11-21 BMRN Sale 30,000 10.00 300,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Swiedler Stuart J (SVP, Clinical Affair of Biomarin Pharmaceutical Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.